Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06533189

Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Protocol: a Pilot Study

Developing a Whole-body Magnetic Resonance Imaging and Diffusion-weighted Imaging State-of-the-art Protocol, a Pilot Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Whole-body magnetic resonance imaging (WB-MRI) is a non-ionizing imaging method that can provide WB coverage using essential imaging contrasts with the possibility to include sequences focusing in specific body-regions as needed per case. WB-MRI is increasingly being used for the management of cancer patients, especially metastatic ones. An integral part of WB-MRI is becoming whole-body diffusion-weighted MRI (WB-DWI) which is a non-invasive tool used for staging and response evaluation in oncologic practice. WB-DWI is an inherently noisy technique, resulting in it accounting for more than 50% of the acquisition time of conventional whole-body MRI studies with overall duration at least 1-hour. Reducing acquisition times, without compromising image or diagnostic quality would facilitate the wider adoption of clinical WBDWI, reducing costs, and improving the patient experience

Conditions

Interventions

TypeNameDescription
DEVICEEnhanced Diffusion SoftwareApplication of specific sequences with the use of Enhanced Diffusion Software during Patient MRI

Timeline

Start date
2024-09-01
Primary completion
2025-12-31
Completion
2026-02-28
First posted
2024-08-01
Last updated
2024-08-01

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06533189. Inclusion in this directory is not an endorsement.